Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review

World Health Organization Sedgh, 2014, Intended and unintended pregnancies worldwide in 2012 and recent trends, Stud Fam Plann, 45, 301, 10.1111/j.1728-4465.2014.00393.x Catalano, 2007, Management of obesity in pregnancy, Obstet Gynecol, 109, 419, 10.1097/01.AOG.0000253311.44696.85 Grimes, 2005, Family planning for obese women: challenges and opportunities, Contraception, 72, 1, 10.1016/j.contraception.2005.04.002 Robinson, 2005, Maternal outcomes in pregnancies complicated by obesity, Obstet Gynecol, 106, 1357, 10.1097/01.AOG.0000188387.88032.41 World Health Organization, 2015 Farr, 2010, U S. Medical Eligibility Criteria for Contraceptive Use 2010: adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use 4th edition, MMWR Recomm Rep, 59, 1 Edelman, 2010, Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review, Contraception, 82, 314, 10.1016/j.contraception.2010.04.016 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Ann Intern Med, 151, 264, 10.7326/0003-4819-151-4-200908180-00135 Hall, 2012, Progestin-only contraceptive pill use among women in the United States, Contraception, 86, 653, 10.1016/j.contraception.2012.05.003 Harris, 2001, Current methods of the US Preventive Services Task Force: a review of the process, Am J Prev Med, 20, 21, 10.1016/S0749-3797(01)00261-6 Yamazaki, 2015, Effect of obesity on the effectiveness of hormonal contraceptives: an individual participant data meta-analysis, Contraception, 92, 445, 10.1016/j.contraception.2015.07.016 Schramm, 2011, The efficacy and safety of an oral contraceptive containing chlormadinone acetate: results of a pooled analysis of noninterventional trials in adult and adolescent women, Contraception, 84, 390, 10.1016/j.contraception.2011.03.024 Dinger, 2011, Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen, Obstet Gynecol, 117, 33, 10.1097/AOG.0b013e31820095a2 Dinger, 2009, Oral contraceptive effectiveness according to body mass index, weight, age, and other factors, Am J Obstet Gynecol, 201, 10.1016/j.ajog.2009.03.017 Vessey, 2001, Oral contraceptive failures and body weight: findings in a large cohort study, J Fam Plann Reprod Health Care, 27, 90, 10.1783/147118901101195092 Holt, 2002, Body weight and risk of oral contraceptive failure, Obstet Gynecol, 99, 820 Nakajima, 2016, Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive, Contraception, 93, 52, 10.1016/j.contraception.2015.09.013 Westhoff, 2012, Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive, Contraception, 85, 235, 10.1016/j.contraception.2011.08.001 Burkman, 2009, Association between efficacy and body weight or body mass index for two low-dose oral contraceptives, Contraception, 79, 424, 10.1016/j.contraception.2008.12.013 Brunner Huber, 2007, Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth, Am J Epidemiol, 166, 1306, 10.1093/aje/kwm221 Brunner Huber, 2006, Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina, Ann Epidemiol, 16, 637, 10.1016/j.annepidem.2006.01.001 Brunner, 2005, The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth, Ann Epidemiol, 15, 492, 10.1016/j.annepidem.2004.10.009 Jick, 2009, The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General Practice Research Database, Contraception, 80, 142, 10.1016/j.contraception.2009.02.013 Holt, 2005, Body mass index, weight, and oral contraceptive failure risk, Obstet Gynecol, 105, 46, 10.1097/01.AOG.0000149155.11912.52 Zieman, 2002, Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data, Fertil Steril, 77, S13, 10.1016/S0015-0282(01)03275-7 Lopez, 2016, Hormonal contraceptives for contraception in overweight or obese women, Cochrane Database Syst Rev, 4 Kaunitz, 2014, Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial, Obstet Gynecol, 10.1097/AOG.0000000000000095 Kaunitz, 2015, Foegh M. Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women, Am J Obstet Gynecol, 212, 10.1016/j.ajog.2014.09.014 Westhoff, 2005, Higher body weight does not affect NuvaRing's efficacy, Obstet Gynecol, 105, 56S Westhoff, 2012, Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women, Am J Obstet Gynecol, 207, 10.1016/j.ajog.2012.04.022 Hammond, 2003, Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties, Contraception, 28, 93, 10.1016/S0010-7824(02)00473-0 Cherala, 2016, Obesity's effect on contraceptive failure is diluted by grouping of progestins, Contraception, 93, 565, 10.1016/j.contraception.2015.12.011 Brunner Huber, 2007, Validity of self-reported height and weight in women of reproductive age, Matern Child Health J, 11, 137, 10.1007/s10995-006-0157-0 Simmons, 2015, Contraception and sexual health in obese women, Best Pract Res Clin Obstet Gynaecol, 29, 466, 10.1016/j.bpobgyn.2014.10.005 Trussell, 2011, Contraceptive failure in the United States, Contraception, 83, 397, 10.1016/j.contraception.2011.01.021